ask="3.87"
ask_size="1000"
average_daily_volume="36502"
bid="3.44"
bid_size="500"
book_value="-0.23"
change="-0.01"
change_from_200_day_moving_average="-0.08"
change_from_50_day_moving_average="0.85"
change_from_52_week_high="-1.93"
change_From_52_week_low="1.76"
change_in_percent="-0.28%"
close="3.56"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.67"
ebitda="-49.36M"
eps_estimate_current_year="-2.25"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.50"
ex_dividend_date="N/A"
float_shares="12319000"
high="3.65"
high_52_weeks="5.49"
last_trade_date="1/31/2017"
last_trade_price="3.56"
last_trade_size="1012"
last_trade_time="4:00pm"
low="3.41"
low_52_weeks="1.80"
market_capitalization="83.94M"
moving_average_200_day="3.64"
moving_average_50_day="2.71"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.00"
open="3.60"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.11%"
percent_change_from_50_day_moving_average="+31.15%"
percent_change_from_52_week_high="-35.15%"
percent_change_from_52_week_low="+97.35%"
previous_close="3.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="28.25"
revenue="2.98M"
shares_outstanding="23578000"
short_ratio="0.41"
stock_exchange="NGM"
symbol="ONS"
volume="69555"
weeks_range_52="1.80 - 5.49"
